- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05055336
Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia
October 6, 2022 updated by: University of Miami
Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia: Toward Individualized Care in Functional Abdominal Pain Disorders
The purpose of this research is to further study the relationship between gastroparesis (GP) (a condition in which the stomach cannot empty itself of food in a normal fashion) and functional dyspepsia (FD) (frequent symptoms of indigestion that have no obvious cause).
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to complete the Pediatric Cardinal Symptoms Questionnaire
- Both parent and child must be able to speak and understand English or Spanish
Exclusion Criteria:
- Have global developmental delay, autism disorder, or psychosis
- Are nonverbal and/or illiterate
- Lack fluency in English or Spanish
- Have other GI comorbidities such as inflammatory bowel disease, celiac disease, eosinophilic esophagitis, peptic ulcer disease, GI malignancy, or gastroesophageal reflux disease responsive to medications (medical records will be reviewed to detect these exclusions)
- Have a history of surgical procedures that could have potentially affected their GI tract anatomy, such as fundoplication or Ladd's procedure.
- Healthy child presenting to their well child care visit must not report a history of dyspepsia, have a history of any gastrointestinal disease, or be taking any medication that can disturb the GI tract motility.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Gastroparesis
Participants in this group are children diagnosed with gastroparesis per gastric emptying scintigraphy.
Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.
|
The gastric emptying breath test is used to diagnose gastroparesis.
Participants ingest spirulina in a meal and samples are taken every 45 minutes for 4 hours.
Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.
|
EXPERIMENTAL: Dyspepsia
Participants in this group are children diagnosed with functional dyspepsia per gastric emptying scintigraphy.
Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.
|
The gastric emptying breath test is used to diagnose gastroparesis.
Participants ingest spirulina in a meal and samples are taken every 45 minutes for 4 hours.
Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.
|
EXPERIMENTAL: Healthy Controls
Participants in this group are children that do not have gastroparesis, functional dyspepsia, or any other gastroenterology condition.
Participants will be getting an ultrasound once.
|
Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric emptying rate
Time Frame: up to 6 months
|
As measured by the spirulina breath test
|
up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of food retained in the stomach
Time Frame: Day 1
|
Fundic accommodation will be reported as the percentage of food retained in the fundus using an ultrasound before and after meal ingestion.
|
Day 1
|
Pediatric Cardinal Symptoms Questionnaire Scores
Time Frame: Up to 6 months
|
The pediatric symptoms questionnaires has a total score ranging from 0-600.
Higher score means worse symptoms.
|
Up to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Liz Febo-Rodriguez, MD, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 1, 2022
Primary Completion (ANTICIPATED)
April 1, 2023
Study Completion (ANTICIPATED)
April 1, 2023
Study Registration Dates
First Submitted
August 23, 2021
First Submitted That Met QC Criteria
September 21, 2021
First Posted (ACTUAL)
September 24, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 10, 2022
Last Update Submitted That Met QC Criteria
October 6, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210662
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyspepsia
-
King Chulalongkorn Memorial HospitalRecruiting
-
Wuhan Central HospitalNot yet recruiting
-
Dong-A ST Co., Ltd.Not yet recruitingFunctional DyspepsiaKorea, Republic of
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Zeria PharmaceuticalRecruitingFunctional DyspepsiaJapan
-
Hong Kong Baptist UniversityXiyuan Hospital of China Academy of Chinese Medical SciencesRecruitingFunctional DyspepsiaHong Kong
-
Seoul National University HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Wonju Severance Christian HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedFunctional DyspepsiaKorea, Republic of
Clinical Trials on Gastric emptying breath test
-
Universitaire Ziekenhuizen KU LeuvenCompletedHealthy | Gastric EmptyingBelgium
-
Cairn DiagnosticsBaylor College of Medicine; Medical College of WisconsinRecruitingGastroparesisUnited States
-
The University of Texas Medical Branch, GalvestonNovartis PharmaceuticalsTerminatedDiabetes | ImmunosuppressionUnited States
-
The University of Texas Health Science Center,...CompletedGastrointestinal Dysfunction | Mitochondrial DisordersUnited States
-
Mayo ClinicRecruitingCirrhosis | Gastric Antral Vascular EctasiaUnited States
-
Uppsala UniversityKarolinska InstitutetCompletedHip Fracture | Gastroparesis | Mild Insufficient Nutrition
-
Herlev HospitalMerck Sharp & Dohme LLC; University of Copenhagen; Diabetesforeningen; Forsknin...CompletedIncretin EffectDenmark
-
Sandwell & West Birmingham Hospitals NHS TrustUnknownGastric Disease
-
University Hospital, LilleGroupement Interrégional de Recherche Clinique et d'Innovation; french patient...Not yet recruiting